Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference
Semler Scientific, Inc. (OTCQB: SMLR) announced that CEO Doug Murphy-Chutorian and CMO Dennis Rosenberg will present at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 4:30 pm ET. They will also engage in one-on-one calls with investors. A live webcast will be accessible under the "Events and Presentations" section of the Semler Scientific website. The presentation will be archived for 90 days.
Semler specializes in technology solutions for healthcare providers, focusing on chronic disease evaluation and management, including its FDA-cleared product QuantaFlo®.
- None.
- None.
SANTA CLARA, Calif., April 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, at 4:30 pm ET. Management will also participate in one-on-one calls with investors.
A live webcast will be available under "Events and Presentations" on the "Investor Info" section of the Semler Scientific website and may be accessed through the following link: https://wsw.com/webcast/needham107/smlr/2276780. The presentation will be archived for a period of 90 days after the conference.
About Semler Scientific, Inc.
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at semlerscientific.com.
CONTACT:
Susan A. Noonan
S.A. Noonan Communications
susan@sanoonan.com
212 966 3650
View original content:http://www.prnewswire.com/news-releases/semler-to-participate-in-the-20th-annual-needham-virtual-healthcare-conference-301263803.html
SOURCE Semler Scientific, Inc.
FAQ
When will Semler Scientific present at the Needham Healthcare Conference?
Who will represent Semler Scientific at the conference?
Is there a webcast available for Semler Scientific's presentation?
How long will the archived presentation be available?
What products does Semler Scientific offer?
